Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

Journal of the American College of Cardiology

Volumn 61, Issue 14, 2013, Pages 1518-1526

  Ruwald, Martin H ^a,b   Ruwald, Anne Christine H ^a,b   Jons, Christian ^b   Alexis, Jeffrey ^a   McNitt, Scott ^a   Zareba, Wojciech ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

beta blockers; heart failure; left bundle branch block; prognosis; resynchronization

Indexed keywords

CARVEDILOL; METOPROLOL;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RESPONSE; CLINICAL EVALUATION; DEATH; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RISK REDUCTION; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CARBAZOLES; CARDIAC RESYNCHRONIZATION THERAPY; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METOPROLOL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPANOLAMINES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84875767744     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.020     Document Type: Article

References (20)

1. A. Rossi, G. Rossi, M. Piacenti, U. Startari, L. Panchetti, M.A. Morales The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials Heart Vessels 23 2008 217 223
2. J.G. Cleland, J.C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
3. A.J. Moss, W.J. Hall, D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
4. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
5. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
6. A.E. Epstein, J.P. Dimarco, K.A. Ellenbogen ACC/AHS/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 51 2008 e1 e62
7. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European trial (COMET): randomised controlled trial Lancet 362 2003 7 13
8. M. Packer, M.B. Fowler, E.B. Roecker Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study Circulation 106 2002 2194 2199
9. A. Hjalmarson, S. Goldstein, B. Fagerberg Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol ER/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) MERIT-HF Study Group JAMA 283 2000 1295 1302
10. J.J. McMurray, S. Adamopoulos, S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Eur J Heart Fail 14 2012 803 869
11. M. Jessup, W.T. Abraham, D.E. Casey 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 119 2009 1977 2016
12. J.T. Heywood, G.C. Fonarow, C.W. Yancy Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF Circ Heart Fail 3 2010 596 605
13. A. Voigt, A. Shalaby, E. Adelstein, S. Saba Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy Clini Cardiol 33 2010 E1 E5
14. X. Shen, C.K. Nair, W.S. Aronow, T. Hee, D.J. Esterbrooks Effect of carvedilol versus metoprolol CR/XL on mortality in patients with heart failure treated with cardiac resynchronization therapy: a Cox multivariate regression analysis Am J Ther 2011 Jun 3 [E-pub ahead of print]
15. A.J. Moss, M.W. Brown, D.S. Cannom Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol Ann Noninvasive Electrocardiol 10 Suppl 2005 34 43
16. H. Greenberg, R.B. Case, A.J. Moss, M.W. Brown, E.R. Carroll, M.L. Andrews Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II) J Am Coll Cardiol 43 2004 1459 1465
17. G.C. Fonarow, W.T. Abraham, N.M. Albert Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Am J Cardiol 102 2008 1524 1529
18. J.G. Cleland, J.C. Daubert, E. Erdmann Baseline characteristics of patients recruited into the CARE-HF study Eur J Heart Fail 7 2005 205 214
19. F.A. McAlister, N. Wiebe, J.A. Ezekowitz, A.A. Leung, P.W. Armstrong Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
20. M. Fiuzat, D. Wojdyla, D. Kitzman Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating outcomes of Exercise Training) trial J Am Coll Cardiol 60 2012 208 215